Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 1/20 | 0.35 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | APLNR | P35414 | 2/20 | 0.32 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.32 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.31 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | CLK1 | P49759 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31751666 | 0.80 | ELOVL1 (0.40) | ACACBKMT2AFFAR1ELOVL1 | |
| SCHEMBL31751133 | 0.78 | ACACB (0.36) | ACACBKMT2A | |
| SCHEMBL3924311 | 0.73 | APP (0.46) | ACACBALOX5KMT2AFFAR1 | |
| SCHEMBL31750774 | 0.70 | KMT2A (0.40) | KRASSOS1KMT2APTGDR2PDE10A | |
| SCHEMBL20865650 | 0.67 | ACHE (0.45) | ALOX5KMT2A | |
| SCHEMBL31546704 | 0.66 | CYP2C19 (0.39) | ACACB | |
| SCHEMBL31546684 | 0.66 | CYP2C19 (0.39) | ACACB | |
| SCHEMBL12825874 | 0.65 | KDR (0.47) | KMT2AEGFRERBB3 | |
| SCHEMBL2800138 | 0.65 | ALOX5 (0.40) | ALOX5KMT2AFFAR1 | |
| SCHEMBL31750819 | 0.64 | ELOVL1 (0.44) | ACACBKMT2AEGFRELOVL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264954-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-12-26 | — | — | WO | disclosed |